BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17428369)

  • 1. Towards diagnostic criteria for the ANCA-associated vasculitides.
    Luqmani RA
    Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S57. PubMed ID: 17428369
    [No Abstract]   [Full Text] [Related]  

  • 2. [ANCA-associated vasculitides. Classifying the disease and its activity according to EULAR/EUVAS recommendations].
    Holle JU; Lamprecht P
    Z Rheumatol; 2009 Feb; 68(1):75-80. PubMed ID: 19093126
    [No Abstract]   [Full Text] [Related]  

  • 3. Discussion of the 2007 British Society for Rheumatology guidelines for management of ANCA-associated vasculitis.
    Villa-Forte A; Hoffman GS
    Nat Clin Pract Rheumatol; 2008 Jun; 4(6):284-5. PubMed ID: 18446138
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antineutrophil cytoplasmic antibody (ANCA). Diagnostic tool in small vessel vasculitis].
    Skogh T; Dahle L
    Lakartidningen; 1997 Mar; 94(10):854-7. PubMed ID: 9102513
    [No Abstract]   [Full Text] [Related]  

  • 5. Classification of the systemic vasculitides: antineutrophil cytoplasmic antibodies, consensus and controversy.
    Hoffman GS
    Clin Exp Rheumatol; 1998; 16(2):111-5. PubMed ID: 9536385
    [No Abstract]   [Full Text] [Related]  

  • 6. Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases.
    Vizjak A; Nagode B; Rott T; Koselj M; Rozman B; Kaplan-Pavlovcic S; Kosnik M; Petric V; Ferluga D
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):665-70. PubMed ID: 11020953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial ANCA testing is useful in monitoring disease activity of patients with ANCA-associated vasculitides.
    Tervaert JW; Stegeman CA; Kallenberg CG
    Sarcoidosis Vasc Diffuse Lung Dis; 1996 Oct; 13(3):241-5. PubMed ID: 8946592
    [No Abstract]   [Full Text] [Related]  

  • 8. ANCA-associated renal vasculitis--epidemiology, diagnostics and treatment.
    Ríhová Z; Jancová E; Merta M; Tesar V
    Prague Med Rep; 2004; 105(3):237-60. PubMed ID: 15782551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
    Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineutrophil cytoplasmic antibodies (ANCA): diagnostic utility and potential role in the pathogenesis of vasculitis.
    Malenica B; Rudolf M; Kozmar A
    Acta Dermatovenerol Croat; 2004; 12(4):294-313. PubMed ID: 15588565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drop the anchor, not the ANCA.
    Wong RC; Phan TG; Steele R; Gillis D; Adelstein S
    Intern Med J; 2002 Mar; 32(3):121-2. PubMed ID: 11887879
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent developments in the classification and assessment of vasculitis.
    Watts RA; Scott DG
    Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):429-43. PubMed ID: 19508949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ANCA (antineutrophil cytoplasmic antibodies). Contribution of ANCA to the understanding of pathogenic mechanisms of systemic vasculitis].
    De Bandt M
    Ann Med Interne (Paris); 1997; 148(8):542-62. PubMed ID: 9538401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification and diagnostic criteria in systemic vasculitis.
    Saleh A; Stone JH
    Best Pract Res Clin Rheumatol; 2005 Apr; 19(2):209-21. PubMed ID: 15857792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antineutrophil cytoplasmic antibody-associated vasculitides.
    Seo P; Stone JH
    Am J Med; 2004 Jul; 117(1):39-50. PubMed ID: 15210387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vasculitis management: discovery of antineutrophil cytoplasmic antibodies (ANCA)].
    Guillevin L
    Presse Med; 2007 May; 36(5 Pt 2):843-4. PubMed ID: 17449373
    [No Abstract]   [Full Text] [Related]  

  • 17. Thoughts about the classification of small vessel vasculitis.
    Falk RJ; Jennette JC
    J Nephrol; 2004; 17 Suppl 8():S3-9. PubMed ID: 15599883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ANCA vasculitis].
    Bernis C
    Nefrologia; 2003; 23(2):103-6. PubMed ID: 12778872
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
    Sinclair D; Stevens JM
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis und therapy of ANCA-associated vasculitis].
    Aries PM; Hellmich B; Gross WL
    Dtsch Med Wochenschr; 2006 Mar; 131(9):443-6. PubMed ID: 16493569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.